{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:29:20Z","timestamp":1792650560854,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jcyt.2013.01.218","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T07:16:58Z","timestamp":1370589418000},"page":"893-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Cell therapy with autologous mesenchymal stem cells\u2014how the disease process impacts clinical considerations"],"prefix":"10.1016","volume":"15","author":[{"given":"Jin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianming","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2013.01.218_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2013.01.218_bib2","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","article-title":"Mesenchymal stem cells reside in virtually all post-natal organs and tissues","volume":"119","author":"da Silva Meirelles","year":"2006","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jcyt.2013.01.218_bib3","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"108","author":"Nauta","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2013.01.218_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cellimm.2009.05.014","article-title":"Histocompatibility testing of cultivated human bone marrow stromal cells: a promising step towards pre-clinical screening for allogeneic stem cell therapy","volume":"259","author":"Koppula","year":"2009","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jcyt.2013.01.218_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1517\/14712598.2011.574119","article-title":"Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions","volume":"11","author":"Wang","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jcyt.2013.01.218_bib7","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/01.CIR.0000124476.32871.E3","article-title":"Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease","volume":"109","author":"Heeschen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcyt.2013.01.218_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1474-9726.2010.00646.x","article-title":"Age-related changes in mesenchymal stem cells derived from rhesus macaque bone marrow","volume":"10","author":"Yu","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.jcyt.2013.01.218_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1525-1594.2009.00824.x","article-title":"Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction","volume":"34","author":"Xin","year":"2010","journal-title":"Artif Organs"},{"key":"10.1016\/j.jcyt.2013.01.218_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mad.2007.12.002","article-title":"Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies","volume":"129","author":"Stolzing","year":"2008","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.jcyt.2013.01.218_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/rej.2009.0986","article-title":"The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction","volume":"13","author":"Fan","year":"2010","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.jcyt.2013.01.218_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/path.2469","article-title":"Why are MSCs therapeutic? New data: new insight","volume":"217","author":"Caplan","year":"2009","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bone.2003.07.005","article-title":"Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells","volume":"33","author":"Stenderup","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.jcyt.2013.01.218_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1474-9726.2008.00377.x","article-title":"Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts","volume":"7","author":"Zhou","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.jcyt.2013.01.218_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/scd.2006.0078","article-title":"Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats","volume":"16","author":"Tokalov","year":"2007","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2013.01.218_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1471-2164-11-229","article-title":"Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells","volume":"11","author":"Wilson","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jcyt.2013.01.218_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2121-12-44","article-title":"Age-related changes in rat bone-marrow mesenchymal stem cell plasticity","volume":"12","author":"Asumda","year":"2011","journal-title":"BMC Cell Biol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.scr.2011.11.002","article-title":"Aging alters tissue resident mesenchymal stem cell properties","volume":"8","author":"Alt","year":"2012","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jcyt.2013.01.218_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1016-8478(23)07336-3","article-title":"A\u00a0number of bone marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with age of rats","volume":"24","author":"Tokalov","year":"2007","journal-title":"Mol Cells"},{"key":"10.1016\/j.jcyt.2013.01.218_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00223-007-9020-6","article-title":"Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions","volume":"80","author":"Seebach","year":"2007","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jcyt.2013.01.218_bib21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bone.2009.08.005","article-title":"Sex-specific compromised bone healing in female rats might be associated with a decrease in mesenchymal stem cell quantity","volume":"45","author":"Strube","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.jcyt.2013.01.218_bib22","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1089\/scd.2010.0280","article-title":"Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells","volume":"20","author":"Katsara","year":"2011","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2013.01.218_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yjmcc.2006.09.016","article-title":"Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1)","volume":"42","author":"Crisostomo","year":"2007","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yjmcc.2005.10.001","article-title":"Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-beta agonist: up-regulation of cardiac heat shock factor-1 and heat shock proteins","volume":"40","author":"Yu","year":"2006","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib25","doi-asserted-by":"crossref","first-page":"H92","DOI":"10.1152\/ajpheart.01247.2004","article-title":"Mechanism of salutary effects of estradiol on organ function after trauma-hemorrhage: upregulation of heme oxygenase","volume":"289","author":"Szalay","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.surg.2007.04.013","article-title":"In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power","volume":"142","author":"Crisostomo","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.jcyt.2013.01.218_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jss.2008.02.006","article-title":"Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia","volume":"152","author":"Erwin","year":"2009","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jcyt.2013.01.218_bib28","doi-asserted-by":"crossref","first-page":"C317","DOI":"10.1152\/ajpcell.00415.2008","article-title":"Role of HIF-1alpha and VEGF in human mesenchymal stem cell proliferation by 17beta-estradiol: involvement of PKC, PI3K\/Akt, and MAPKs","volume":"296","author":"Yun","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jsbmb.2009.02.001","article-title":"Steroid regulation of proliferation and osteogenic differentiation of bone marrow stromal cells: a gender difference","volume":"114","author":"Hong","year":"2009","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopha.2011.11.014","article-title":"The protective effect of 17\u03b2-estradiol against hydrogen peroxide-induced apoptosis on mesenchymal stem cell","volume":"66","author":"Chen","year":"2012","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jcyt.2013.01.218_bib31","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1089\/ten.2006.12.2747","article-title":"Modulations of 17-beta estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells","volume":"12","author":"Hong","year":"2006","journal-title":"Tissue Eng"},{"issue":"Suppl","key":"10.1016\/j.jcyt.2013.01.218_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jcb.1096","article-title":"Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice","volume":"36","author":"Zhou","year":"2001","journal-title":"J\u00a0Cell Biochem Suppl"},{"key":"10.1016\/j.jcyt.2013.01.218_bib33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S1016-8478(23)14021-0","article-title":"Estrogen receptor-alpha mediates the effects of estradiol on telomerase activity in\u00a0human mesenchymal stem cells","volume":"26","author":"Cha","year":"2008","journal-title":"Mol Cells"},{"key":"10.1016\/j.jcyt.2013.01.218_bib34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1089\/scd.2007.0008","article-title":"Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases","volume":"16","author":"Zhao","year":"2007","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2013.01.218_bib35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.leukres.2005.12.010","article-title":"Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia","volume":"30","author":"Zhao","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.jcyt.2013.01.218_bib36","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.leu.2404621","article-title":"Bone marrow mesenchymal stem cells are abnormal in multiple myeloma","volume":"21","author":"Corre","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2013.01.218_bib37","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1080\/10428190701593644","article-title":"Mesenchymal stem cell abnormalities in patients with multiple myeloma","volume":"48","author":"Garderet","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcyt.2013.01.218_bib38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.arcmed.2010.11.008","article-title":"Impairment in immunomodulatory function of mesenchymal stem cells from multiple myeloma patients","volume":"41","author":"Li","year":"2010","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jcyt.2013.01.218_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.leu.2404466","article-title":"Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma","volume":"21","author":"Arnulf","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2013.01.218_bib40","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/leu.2009.65","article-title":"Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors","volume":"23","author":"Garayoa","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2013.01.218_bib41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00277-009-0892-6","article-title":"Poor potential of proliferation and differentiation in bone marrow mesenchymal stem cells derived from children with severe aplastic anemia","volume":"89","author":"Chao","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib42","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/scd.2009.0286","article-title":"Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes","volume":"19","author":"Klaus","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2013.01.218_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1751-553X.2010.01285.x","article-title":"Biologic characteristics of bone marrow-derived mesenchymal stem cells from a patient with thalassemia syndrome","volume":"33","author":"Yoon","year":"2011","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ard.2007.076174","article-title":"Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis","volume":"67","author":"Kastrinaki","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2013.01.218_bib45","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3109\/14653240903051558","article-title":"Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura","volume":"11","author":"P\u00e9rez-Sim\u00f3n","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2013.01.218_bib46","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/0961203310361482","article-title":"Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"19","author":"Nie","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jcyt.2013.01.218_bib47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0961203306075793","article-title":"Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"16","author":"Sun","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.jcyt.2013.01.218_bib48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/ard.2007.071233","article-title":"Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis","volume":"67","author":"Larghero","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcyt.2013.01.218_bib49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000281826","article-title":"Diabetes induced changes in rat mesenchymal stem cells","volume":"191","author":"Stolzing","year":"2010","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.jcyt.2013.01.218_bib50","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1359\/JBMR.050514","article-title":"Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone","volume":"20","author":"Kume","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcyt.2013.01.218_bib51","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/scd.2009.0453","article-title":"Bone marrow-derived stromal cells from amyotrophic lateral sclerosis patients have diminished stem cell capacity","volume":"19","author":"Cho","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2013.01.218_bib52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3727\/096368908784153940","article-title":"Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients","volume":"17","author":"Ferrero","year":"2008","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2013.01.218_bib53","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/1352458510371959","article-title":"Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis","volume":"16","author":"Mallam","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.jcyt.2013.01.218_bib54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jneuroim.2008.05.006","article-title":"Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: implication for assessment of disease activity and treatment","volume":"199","author":"Mazzanti","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11626-008-9093-1","article-title":"Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson's disease","volume":"44","author":"Zhang","year":"2008","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.jcyt.2013.01.218_bib56","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.exphem.2005.05.006","article-title":"T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia","volume":"33","author":"Bacigalupo","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/10245330701255288","article-title":"GATA-1, -2 and -3 genes expression in bone marrow microenvironment with chronic aplastic anemia","volume":"12","author":"Wu","year":"2007","journal-title":"Hematology"},{"key":"10.1016\/j.jcyt.2013.01.218_bib58","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood.V99.5.1610","article-title":"Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect","volume":"99","author":"Papadaki","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2013.01.218_bib59","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2008-01-135335","article-title":"Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura","volume":"112","author":"Yu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2013.01.218_bib60","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","article-title":"Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells","volume":"26","author":"Selmani","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2013.01.218_bib61","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.11240","article-title":"Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction","volume":"92","author":"Prevosto","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2013.01.218_bib62","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1475-2840-9-66","article-title":"Advanced glycation end products induce chemokine\/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells","volume":"9","author":"Yang","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib63","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10565-008-9113-7","article-title":"Influence of lactic acid on the proliferation, metabolism, and differentiation of rabbit mesenchymal stem cells","volume":"25","author":"Chen","year":"2009","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib64","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3748\/wjg.v13.i11.1743","article-title":"Comparison of biological characteristics of marrow mesenchymal stem cells in hepatitis B patients and normal adults","volume":"13","author":"Peng","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib65","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2893.2008.00978.x","article-title":"Bone marrow-derived mesenchymal stem cells are capable of mediating hepatitis B virus infection in injured tissues","volume":"15","author":"Rong","year":"2008","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jcyt.2013.01.218_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2009.01.007","article-title":"Cigarette smoking: an undertreated risk factor for cardiovascular disease","volume":"205","author":"Erhardt","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jcyt.2013.01.218_bib67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/scd.2008.0032","article-title":"Functional nicotinic and muscarinic receptors on mesenchymal stem cells","volume":"18","author":"Hoogduijn","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2013.01.218_bib68","first-page":"29","article-title":"The effect of nicotine on the mechanical properties of mesenchymal stem cells","volume":"4","author":"Ruiz","year":"2012","journal-title":"Cell Health Cytoskelet"},{"key":"10.1016\/j.jcyt.2013.01.218_bib69","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lfs.2011.10.019","article-title":"Effects of nicotine on proliferation and osteoblast differentiation in human alveolar bone marrow-derived mesenchymal stem cells","volume":"90","author":"Kim","year":"2012","journal-title":"Life Sci"},{"key":"10.1016\/j.jcyt.2013.01.218_bib70","first-page":"81","article-title":"Effect of nicotine on chondrogenic differentiation of rat bone marrow mesenchymal stem cells in alginate bead culture","volume":"22","author":"Deng","year":"2012","journal-title":"Biomed Mater Eng"},{"key":"10.1016\/j.jcyt.2013.01.218_bib71","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/scd.2012.0434","article-title":"Nicotine alters microRNA expression and hinders human adult stem cell regenerative potential","volume":"22","author":"Ng","year":"2013","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2013.01.218_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.reprotox.2010.10.007","article-title":"Cigarette smoke inhibits recruitment of bone-marrow-derived stem cells to the uterus","volume":"31","author":"Zhou","year":"2011","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib73","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/toxsci\/kfl101","article-title":"The effects of anticholinergic insecticides on human mesenchymal stem cells","volume":"94","author":"Hoogduijn","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jcyt.2013.01.218_bib74","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(99)04466-9","article-title":"Reduced bone formation after exposure to organophosphates","volume":"354","author":"Compston","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2013.01.218_bib75","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/10428190109097705","article-title":"Bone marrow stromal damage after chemo\/radiotherapy: occurrence, consequences and possibilities of treatment","volume":"42","author":"Banfi","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcyt.2013.01.218_bib76","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2141.2004.05200.x","article-title":"Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents","volume":"127","author":"Li","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib77","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Ko\u00e7","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib78","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1634\/stemcells.2006-0108","article-title":"Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction","volume":"24","author":"Mueller","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2013.01.218_bib79","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00277-010-1141-8","article-title":"Alkylating chemotherapeutic agents cyclophosphamide and melphalan cause functional injury to human bone marrow-derived mesenchymal stem cells","volume":"90","author":"Kemp","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib80","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00277-009-0896-2","article-title":"Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy","volume":"89","author":"Kemp","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib81","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.exphem.2011.08.009","article-title":"The aging effect of chemotherapy on cultured human mesenchymal stem cells","volume":"39","author":"Buttiglieri","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib82","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/TP.0b013e31818aa536","article-title":"Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin","volume":"86","author":"Hoogduijn","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2013.01.218_bib83","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/TP.0b013e31818bd96f","article-title":"Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus","volume":"86","author":"Poncelet","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2013.01.218_bib84","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/cr.2007.4","article-title":"Immunosuppressive properties of cloned bone marrow mesenchymal stem cells","volume":"17","author":"Xu","year":"2007","journal-title":"Cell Res"},{"key":"10.1016\/j.jcyt.2013.01.218_bib85","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1016\/j.transproceed.2009.08.030","article-title":"Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells","volume":"41","author":"Buron","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jcyt.2013.01.218_bib86","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/TP.0b013e3181a99079","article-title":"Mesenchymal stem cell and immunosuppressive drug interactions","volume":"87","author":"Buron","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2013.01.218_bib87","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.exphem.2010.10.009","article-title":"Human adipose tissue-derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF-\u03baB signaling","volume":"39","author":"Shi","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2013.01.218_bib88","first-page":"516","article-title":"Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory\/suppressive phenotype","volume":"90","author":"Maccario","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2013.01.218_bib89","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbmt.2005.08.039","article-title":"Human mesenchymal stem cells and cyclosporin A exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes","volume":"11","author":"Maccario","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2013.01.218_bib90","doi-asserted-by":"crossref","first-page":"07B314","DOI":"10.1063\/1.3072821","article-title":"Labeling of human mesenchymal stem cell: comparison between paramagnetic and superparamagnetic agents","volume":"105","author":"Yang","year":"2009","journal-title":"J\u00a0Appl Phys"},{"key":"10.1016\/j.jcyt.2013.01.218_bib91","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/nbm.1487","article-title":"The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells","volume":"23","author":"Kim","year":"2010","journal-title":"NMR Biomed"},{"key":"10.1016\/j.jcyt.2013.01.218_bib92","first-page":"317","article-title":"Assessment of biological characteristics of mesenchymal stem cells labeled with superparamagnetic iron oxide particles in vitro","volume":"5","author":"Sun","year":"2012","journal-title":"Mol Med Report"},{"key":"10.1016\/j.jcyt.2013.01.218_bib93","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/nbm.925","article-title":"Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis","volume":"17","author":"Kostura","year":"2004","journal-title":"NMR Biomed"},{"key":"10.1016\/j.jcyt.2013.01.218_bib94","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jcyt.2013.01.218_bib95","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/scd.2008.0092","article-title":"Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury","volume":"18","author":"T\u00f6gel","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2013.01.218_bib96","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1517\/14712598.2011.606212","article-title":"Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing","volume":"11","author":"Badiavas","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jcyt.2013.01.218_bib97","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.stem.2008.07.020","article-title":"New opportunities: the use of nanotechnologies to manipulate and track stem cells","volume":"3","author":"Ferreira","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2013.01.218_bib98","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.stem.2012.02.005","article-title":"Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease","volume":"10","author":"Ranganath","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2013.01.218_bib99","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/scrt34","article-title":"New concepts on the immune modulation mediated by mesenchymal stem cells","volume":"1","author":"Bunnell","year":"2010","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2013.01.218_bib100","doi-asserted-by":"crossref","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","article-title":"A\u00a0new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype","volume":"5","author":"Waterman","year":"2010","journal-title":"PLoS One"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324913004891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324913004891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:17:41Z","timestamp":1761430661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324913004891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":100,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1465324913004891"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2013.01.218","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell therapy with autologous mesenchymal stem cells\u2014how the disease process impacts clinical considerations","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2013.01.218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}